This paper is only available as a PDF. To read, Please Download here.
Sickle cell disease (SCD) pain is debilitating and severely diminishes patients’ quality
of life. A significant cause of SCD pain is vaso-oclusion, however, pain in SCD can
also arise from chronic tissue inflammation and neuropathy. Our lab is interested
in identifying novel peripheral targets for treating chronic SCD pain. Transient receptor
potential (TRP) channels are among these targets, as they have known somatosensory
functions. One of these, TRPV4, is a nonselective cation channel involved in naïve
somatosensation, as well as inflammatory and neuropathic pain. TRPV4 is expressed
in dorsal root ganglia (DRG) neurons, the primary detectors and transducers of somatosensory
information, and in keratinocytes, which compose the majority of the epidermis and
are located proximal to afferent terminals in the skin. Further, inflammatory factors
that interact with TRPV4, including neutrophil elastase and endothelin-1, are prevalent
in SCD. Thus, TRPV4 is a likely contributor to SCD pain. In this study we investigated
the role of TRPV4 in persistent SCD somatic hypersensitivity. First, we demonstrated
that punctate mechanical allodynia observed in SCD mice was completely and dose-dependently
blocked by a TRPV4 antagonist. Functional analysis of small-diameter DRG neurons (many
of which are nociceptors in rodents) from SCD mice revealed a moderate TRPV4-mediated
increase of calcium flux, and blocking TRPV4 receptors reduced the proportion of mechanically-sensitive
neurons from SCD mice. In contrast to these modest DRG data, we found keratinocytes
from SCD mice display robust TRPV4 agonist-induced calcium flux compared to WT controls.
Given keratinocytes are profuse throughout the skin and are positioned alongside sensory
nerve terminals, this evidence suggests keratinocytes play a pivotal role in TRPV4-mediated
SCD hypersensitivity. Together, these data suggest TRPV4 plays an integral role in
SCD evoked behavioral hypersensitivity, an effect that is likely due to sensitized
TRPV4-mediated keratinocyte, and to a lesser extent DRG, activity in these mice. Grant
support from R01 NS070711 NIH/NINDS.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to The Journal of PainAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
Article info
Identification
Copyright
© 2022 Published by Elsevier Inc.